More on SLN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.74 |
|
|||
| Open | $14.70 | ||||
| 52 Wk High | $0.27 | ||||
| 52 Wk Low | $0.18 | ||||
| Day High | $15.28 | ||||
| Day Low | $14.10 | ||||
| P/E | N/A | ||||
| EPS | $-0.44 | ||||
| Volume | 140,098 | ||||
- William Blair Issues Conviction List for September
- Silence Therapeutics closes $201M public offering of ADSs
- Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
- Silence Therapeutics prices $175 million public offering at $13.50 per ADS
- Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
- Silence Therapeutics (SLN) PT Raised to $32 at Morgan Stanley
- Silence Therapeutics launches $150 million ADS public offering
- Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
- The Catalysts are Back: Socket Mobile Breaks Out while Biotechs Race Toward Major Milestones
- Silence Therapeutics plc (SLN) Tops Q2 EPS by 5c
Entities mentioned with SLN
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Morgan Stanley | View Related Stories »
- Show More...
